CLEC8A AND P-SELECTIN: NEW TUMOR MARKERS FOR DIAGNOSIS OF BREAST CANCER AND EVALUATION OF CHEMOTHERAPY EFFICIENCY IN SUPPRESSING IT. CMN 2024, 6 (2), 7479-7595.